Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 8/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 5/20 | 0.40 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.40 |
| ▸ | GLI1 | P08151 | 1/20 | 0.40 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.35 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.33 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.33 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6581948 | 1.00 | DPP4 (0.44) | DPP4DPP9DPP8GLI1SMYD3 | |
| SCHEMBL30537960 | 1.00 | DPP4 (0.44) | DPP4DPP9DPP8GLI1SMYD3 | |
| SCHEMBL8259677 | 1.00 | DPP4 (0.44) | DPP4DPP9DPP8GLI1SMYD3 | |
| SCHEMBL5471209 | 1.00 | DPP4 (0.44) | DPP4DPP9DPP8GLI1SMYD3 | |
| Hydrochloric Acid SCHEMBL1465100 | 0.98 | DPP4 (0.42) | DPP4DPP9DPP8GLI1SMYD3 | |
| Hydrochloric Acid SCHEMBL1464735 | 0.98 | DPP4 (0.42) | DPP4DPP9DPP8GLI1SMYD3 | |
| Hydrochloric Acid SCHEMBL4208729 | 0.98 | DPP4 (0.42) | DPP4DPP9DPP8GLI1SMYD3 | |
| Trifluoroacetic Acid SCHEMBL2496511 | 0.88 | DPP4 (0.37) | DPP4DPP9DPP8GLI1SMYD3 | |
| Trifluoroacetic Acid SCHEMBL2494834 | 0.88 | DPP4 (0.37) | DPP4DPP9DPP8GLI1SMYD3 | |
| Trifluoroacetic Acid SCHEMBL2497613 | 0.88 | DPP4 (0.37) | DPP4DPP9DPP8GLI1SMYD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090312310-A1 | Imidazothiazole derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-12-17 | — | — | US | disclosed |
| US-20090312310-A1 | Imidazothiazole derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-12-17 | — | — | US | disclosed |
| US-20090312310-A1 | Imidazothiazole derivatives | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-12-17 | — | — | US | disclosed |
| EP-2103619-A1 | IMIDAZOTHIAZOLE DERIVATIVES | Daiichi Sankyo Company, Limited (JP) | 2009-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090312310-A1 | Imidazothiazole derivatives | TP53, MDM2, TP53BP1 | DPP4 2929/4885DPP9 3492/4885DPP8 3304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.